Keir, S. T., Roskoski, M. A., Kragh, M., Pederson, M. W., Jacobsen, H. J., Horak, I. D., … Bigner, D. D. (2013). Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts. In CANCER RESEARCH (Vol. 73). https://doi.org/10.1158/1538-7445.AM2013-4322

Keir, Stephen T., Martin A. Roskoski, Michael Kragh, Mikkel W. Pederson, Helle J. Jacobsen, Ivan D. Horak, Henry S. Friedman, and Darell D. Bigner. “Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts.” In CANCER RESEARCH, Vol. 73, 2013. https://doi.org/10.1158/1538-7445.AM2013-4322.

Keir ST, Roskoski MA, Kragh M, Pederson MW, Jacobsen HJ, Horak ID, et al. Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts. In: CANCER RESEARCH. 2013.

Keir, Stephen T., et al. “Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts.” CANCER RESEARCH, vol. 73, no. 8, 2013. Wos-lite, doi:10.1158/1538-7445.AM2013-4322.

Keir ST, Roskoski MA, Kragh M, Pederson MW, Jacobsen HJ, Horak ID, Friedman HS, Bigner DD. Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts. CANCER RESEARCH. 2013.